Epidemiology of
Africa, Northern
/ epidemiology
Chlamydia Infections
/ epidemiology
Female
Gonorrhea
/ epidemiology
Herpes Genitalis
/ epidemiology
Humans
Middle East
/ epidemiology
Sex Workers
/ statistics & numerical data
Sexually Transmitted Diseases
/ epidemiology
Syphilis
/ epidemiology
Trichomonas Vaginitis
/ epidemiology
Journal
Journal of global health
ISSN: 2047-2986
Titre abrégé: J Glob Health
Pays: Scotland
ID NLM: 101578780
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
entrez:
31
7
2019
pubmed:
31
7
2019
medline:
10
8
2019
Statut:
ppublish
Résumé
The epidemiology of sexually transmitted infections (STIs) and the role of commercial heterosexual sex networks in driving STI transmission in the Middle East and North Africa (MENA) region remain largely unknown. To characterize the epidemiology of A systematic review on ten international, regional, and country-level databases was conducted, and reported following PRISMA guidelines. Pooled prevalences of current and/or ever infection for each STI were estimated using random-effects meta-analyses. Sources of between-study heterogeneity were investigated through random-effects meta-regressions. One STI infection levels among FSWs in MENA are considerable, supporting a key role for commercial heterosexual sex networks in transmission dynamics, and highlighting the health needs of this neglected and vulnerable population. Syphilis prevalence in FSWs appears to have been declining for at least three decades. Gaps in evidence persist for multiple countries.
Sections du résumé
BACKGROUND
BACKGROUND
The epidemiology of sexually transmitted infections (STIs) and the role of commercial heterosexual sex networks in driving STI transmission in the Middle East and North Africa (MENA) region remain largely unknown.
OBJECTIVE
OBJECTIVE
To characterize the epidemiology of
METHODS
METHODS
A systematic review on ten international, regional, and country-level databases was conducted, and reported following PRISMA guidelines. Pooled prevalences of current and/or ever infection for each STI were estimated using random-effects meta-analyses. Sources of between-study heterogeneity were investigated through random-effects meta-regressions.
RESULTS
RESULTS
One
CONCLUSIONS
CONCLUSIONS
STI infection levels among FSWs in MENA are considerable, supporting a key role for commercial heterosexual sex networks in transmission dynamics, and highlighting the health needs of this neglected and vulnerable population. Syphilis prevalence in FSWs appears to have been declining for at least three decades. Gaps in evidence persist for multiple countries.
Identifiants
pubmed: 31360448
doi: 10.7189/jogh.09.020408
pii: jogh-09-020408
pmc: PMC6642815
doi:
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
020408Subventions
Organisme : Medical Research Council
ID : MR/R010161/1
Pays : United Kingdom
Déclaration de conflit d'intérêts
Competing interests: The authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare no competing interests.
Références
Saudi Med J. 2000 Apr;21(4):355-60
pubmed: 11533818
Herpes. 2002 Jul;9(2):38-45
pubmed: 12106510
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
Sex Transm Infect. 2004 Jun;80(3):174-82
pubmed: 15169997
Sex Transm Infect. 2005 Apr;81(2):180-1
pubmed: 15800100
Sex Transm Infect. 2006 Jun;82 Suppl 3:iii18-25
pubmed: 16735288
Lancet. 2007 Jan 13;369(9556):132-8
pubmed: 17223476
Am J Trop Med Hyg. 1991 Dec;45(6):653-9
pubmed: 1763791
Int J Public Health. 2007;52(3):166-72
pubmed: 17958283
Sex Health. 2008 Mar;5(1):9-16
pubmed: 18361849
Sex Transm Dis. 2008 Nov;35(11):946-59
pubmed: 18685546
AIDS. 1991 Jul;5(7):902-4
pubmed: 1892603
Sex Transm Infect. 2009 Apr;85 Suppl 2:ii8-16
pubmed: 19307351
J Coll Physicians Surg Pak. 2009 Apr;19(4):228-31
pubmed: 19356337
Curr Opin HIV AIDS. 2009 Jul;4(4):240-6
pubmed: 19532059
Am J Public Health. 2009 Sep;99(9):1562-7
pubmed: 19608961
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Antimicrob Agents Chemother. 2010 Feb;54(2):583-9
pubmed: 19805553
Int J STD AIDS. 1991 Mar-Apr;2(2):119-23
pubmed: 2043703
J Pak Med Assoc. 2010 May;60(5):353-6
pubmed: 20527605
AIDS. 2010 Jul;24 Suppl 2:S5-23
pubmed: 20610949
AIDS. 2010 Jul;24 Suppl 2:S69-75
pubmed: 20610952
Sex Transm Infect. 2010 Dec;86(7):500-5
pubmed: 20656718
Curr Opin Infect Dis. 2011 Feb;24(1):50-5
pubmed: 21150594
Epidemics. 2010 Dec;2(4):173-82
pubmed: 21352788
BMC Infect Dis. 2011 May 11;11:119
pubmed: 21569319
PLoS Med. 2010 Aug;8(8):e1000444
pubmed: 21829329
East Afr Med J. 1990 Jul;67(7):466-72
pubmed: 2226225
N Engl J Med. 2012 Feb 9;366(6):485-7
pubmed: 22316442
Med Clin North Am. 1990 Nov;74(6):1339-52
pubmed: 2246943
Clin Infect Dis. 2012 May;54 Suppl 4:S339-42
pubmed: 22544200
Sex Transm Infect. 2013 Jun;89(4):311-9
pubmed: 23112339
Adv Biomed Res. 2012;1:5
pubmed: 23210064
Sex Transm Infect. 2013 Sep;89 Suppl 2:ii48-52
pubmed: 23220785
Sex Transm Infect. 2013 Nov;89 Suppl 3:iii11-16
pubmed: 23434789
Qual Health Res. 2013 Jun;23(6):782-94
pubmed: 23515299
Sex Transm Infect. 2013 Nov;89 Suppl 3:iii5-9
pubmed: 23596206
Iran J Public Health. 2012 Dec 01;41(12):60-5
pubmed: 23641392
Sex Transm Infect. 2013 Nov;89 Suppl 3:iii57-60
pubmed: 23863874
J Epidemiol Community Health. 2013 Nov 1;67(11):974-8
pubmed: 23963506
Int J STD AIDS. 2014 Feb;25(2):155-61
pubmed: 23970644
Sex Transm Infect. 2013 Nov;89 Suppl 3:iii1-4
pubmed: 24191291
Curr Opin Infect Dis. 2014 Feb;27(1):62-7
pubmed: 24275696
Curr Opin HIV AIDS. 2014 Mar;9(2):183-91
pubmed: 24445372
Vaccine. 2014 Mar 20;32(14):1630-7
pubmed: 24480024
Vaccine. 2014 Mar 20;32(14):1527-35
pubmed: 24581979
Arch Inst Pasteur Alger. 1989;57:73-82
pubmed: 2489406
PLoS Med. 2014 Jun 17;11(6):e1001663
pubmed: 24937136
Int J STD AIDS. 2015 Jul;26(8):556-64
pubmed: 25122576
Epidemics. 2014 Sep;8:9-17
pubmed: 25240899
PLoS One. 2015 Jan 21;10(1):e114989
pubmed: 25608026
Sex Health. 2015 Apr;12(2):103-9
pubmed: 25702043
Int J Community Based Nurs Midwifery. 2015 Apr;3(2):76-83
pubmed: 26005687
Iran J Psychiatry Behav Sci. 2015 Jun;9(2):e1047
pubmed: 26288640
AIDS Care. 2016;28(4):487-90
pubmed: 26565671
PLoS One. 2015 Dec 08;10(12):e0143304
pubmed: 26646541
Emerg Infect Dis. 2016 Jan;22(1):88-91
pubmed: 26689861
Int J Infect Dis. 2016 Mar;44:1-3
pubmed: 26780269
Sex Transm Dis. 2016 Apr;43(4):255-7
pubmed: 26967303
Vaccine. 2016 Jun 3;34(26):2939-2947
pubmed: 27105564
PLoS Negl Trop Dis. 2016 May 11;10(5):e0004711
pubmed: 27167068
MMWR Surveill Summ. 2016 Jul 15;65(7):1-19
pubmed: 27414503
J Clin Microbiol. 1988 Apr;26(4):662-7
pubmed: 2835389
AIDS. 2017 Jul 31;31(12):1721-1732
pubmed: 28514276
PLoS Med. 2017 Jun 27;14(6):e1002330
pubmed: 28654670
PLoS Med. 2017 Jul 7;14(7):e1002344
pubmed: 28686231
J Int Assoc Provid AIDS Care. 2017 Nov/Dec;16(6):608-614
pubmed: 29017374
Lancet Glob Health. 2017 Nov;5(11):e1054-e1055
pubmed: 29025620
Lancet Glob Health. 2017 Nov;5(11):e1113-e1122
pubmed: 29025633
Clin Infect Dis. 2018 Apr 3;66(8):1184-1191
pubmed: 29136161
Int J Infect Dis. 2018 Mar;68:4-12
pubmed: 29253710
Int J Health Policy Manag. 2017 Jul 08;7(3):225-230
pubmed: 29524951
F1000Res. 2018 Mar 27;7:400
pubmed: 29636908
AIDS. 2018 Jun 19;32(10):1343-1352
pubmed: 29794495
Antibiotics (Basel). 2018 Jun 15;7(2):null
pubmed: 29914071
BMC Med. 2019 Jun 24;17(1):119
pubmed: 31230594
Genitourin Med. 1988 Dec;64(6):396-7
pubmed: 3224977
Genitourin Med. 1987 Oct;63(5):326-8
pubmed: 3500110
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Br J Vener Dis. 1983 Feb;59(1):53-5
pubmed: 6824908
Trans R Soc Trop Med Hyg. 1994 Jan-Feb;88(1):55-6
pubmed: 8154002
J Infect Dis. 1996 Oct;174 Suppl 2:S134-43
pubmed: 8843243
Int J Antimicrob Agents. 1997 Jan;9(3):175-9
pubmed: 9552714
J Acquir Immune Defic Syndr Hum Retrovirol. 1998 May 1;18(1):73-9
pubmed: 9593461
Lancet. 1998;351 Suppl 3:5-7
pubmed: 9652712